{
    "biomarker_id": "BB3841-1",
    "biomarker_canonical_id": "BB3841",
    "condition": {
        "recommended_name": {
            "id": "DOID:0060548",
            "resource": "Disease Ontology",
            "url": "https://disease-ontology.org/term/DOID:0060548",
            "name": "luminal breast carcinoma A",
            "description": "A breast carcinoma that is characterized by high expression of genes characteristic of luminal epithelial cells, including estrogen receptor (ER), estrogen regulated protein LIV-1, and the transcription factors hepatocyte nuclear factor 3, HNF3A, XBP1, and GATA 3."
        },
        "synonyms": [
            {
                "id": "DOID:0060548",
                "resource": "Disease Ontology",
                "url": "https://disease-ontology.org/term/DOID:0060548",
                "name": "Luminal A Breast Carcinoma",
                "description": ""
            }
        ],
        "id": "DOID:0060548"
    },
    "biomarker_component": [
        {
            "biomarker": "increased level of MUCT on MUC1",
            "assessed_biomarker_entity_id": "P15941-1",
            "assessed_entity_type": "protein",
            "assessed_biomarker_entity": {
                "recommended_name": "Mucin-1",
                "synonyms": [
                    {
                        "synonym": "Polymorphic epithelial mucin"
                    },
                    {
                        "synonym": "PEM"
                    },
                    {
                        "synonym": "Krebs von den Lungen-6"
                    },
                    {
                        "synonym": "KL-6"
                    },
                    {
                        "synonym": "Tumor-associated epithelial membrane antigen"
                    },
                    {
                        "synonym": "EMA"
                    },
                    {
                        "synonym": "Peanut-reactive urinary mucin"
                    },
                    {
                        "synonym": "PUM"
                    },
                    {
                        "synonym": "Cancer antigen 15-3"
                    },
                    {
                        "synonym": "CA 15-3"
                    },
                    {
                        "synonym": "Tumor-associated mucin"
                    },
                    {
                        "synonym": "MUC1-CT"
                    },
                    {
                        "synonym": "Breast carcinoma-associated antigen DF3"
                    },
                    {
                        "synonym": "PEMT"
                    },
                    {
                        "synonym": "Episialin"
                    },
                    {
                        "synonym": "Carcinoma-associated mucin"
                    },
                    {
                        "synonym": "H23AG"
                    }
                ]
            },
            "specimen": [
                {
                    "name": "",
                    "namespace": "UBERON",
                    "id": "0008367",
                    "url": "http://purl.obolibrary.org/obo/UBERON_0008367",
                    "loinc_code": ""
                }
            ],
            "evidence_source": [
                {
                    "id": "BB3841-1",
                    "database": "BiomarkerKB",
                    "url": "https://biomarkerkb.org/biomarker/BB3841-1"
                },
                {
                    "id": "40492697",
                    "database": "PubMed",
                    "url": "",
                    "tags": [
                        "assessed_biomarker_entity_id",
                        " assessed_biomarker_entiy",
                        " assessed_entity_type",
                        " biomarker",
                        " specimen"
                    ],
                    "evidence_list": [
                        {
                            "evidence": "In addition, there is an increase of 2.2% in MUCT levels at t = 80 h is observed, despite the inhibitor tangentially acting on C1GALT1 due to a weak binding affinity of the inhibitor to the enzyme."
                        }
                    ]
                }
            ]
        }
    ],
    "best_biomarker_role": [
        {
            "role": ""
        }
    ],
    "evidence_source": [
        {
            "id": "BB3841-1",
            "database": "BiomarkerKB",
            "url": "https://biomarkerkb.org/biomarker/BB3841-1"
        },
        {
            "id": "40492697",
            "database": "PubMed",
            "url": "",
            "tags": [
                "condition"
            ],
            "evidence_list": [
                {
                    "evidence": "In addition, there is an increase of 2.2% in MUCT levels at t = 80 h is observed, despite the inhibitor tangentially acting on C1GALT1 due to a weak binding affinity of the inhibitor to the enzyme."
                }
            ]
        }
    ],
    "crossref": [
        {
            "id": "BB3841-1",
            "database": "BiomarkerKB",
            "url": "https://biomarkerkb.org/biomarker/BB3841-1",
            "categories": [
                "Biomarkers"
            ]
        }
    ],
    "citation": [],
    "section_stats": [
        {
            "table_id": "biomarker_component",
            "table_stats": [
                {
                    "field": "total",
                    "count": 1
                }
            ],
            "sort_fields": [
                "biomarker",
                "assessed_biomarker_entity_id",
                "assessed_entity_type",
                "assessed_biomarker_entity.recommended_name"
            ]
        },
        {
            "table_id": "citation",
            "table_stats": [
                {
                    "field": "total",
                    "count": 0
                }
            ],
            "sort_fields": []
        }
    ]
}